Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    ADRENOCORTICAL CARCINOMA, HEREDITARY
Show Display Options
Download search resultsDownload the search results for:
ADRENOCORTICAL CARCINOMA, HEREDITARY (2 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Conditions: Peritoneal Neoplasms;   Retroperitoneal Neoplasms;   Gastrointestinal Neoplasms;   Adenocarcinoma;   Neuroblastoma;   Ovarian Neoplasms;   Sarcoma;   Adrenocortical Carcinoma;   Wilms Tumor;   Rhabdomyosarcoma;   Desmoplastic Small Round Cell Tumor
Interventions: Drug: CHPP of Cisplatin;   Procedure: Abdominal Surgery
2 Completed Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Conditions: Adult Rhabdomyosarcoma;   Adult Synovial Sarcoma;   Childhood Hepatoblastoma;   Childhood Synovial Sarcoma;   Previously Treated Childhood Rhabdomyosarcoma;   Recurrent Adrenocortical Carcinoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Childhood Liver Cancer;   Recurrent Childhood Rhabdomyosarcoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma;   Recurrent Retinoblastoma;   Recurrent Wilms Tumor and Other Childhood Kidney Tumors
Interventions: Biological: cixutumumab;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years